News Archives - Page 31 of 775

FridayDec 19, 2025 9:00 am

Safe Pro Group Inc. (NASDAQ: SPAI) Files Patent for the Company’s Computer Vision Technology Analysis Algorithm

The algorithm outlined in the patent application describes an approach to enhancing the detection precision and accuracy of AI when used to detect small objects in drone imagery. This patent filing is the latest in the company’s IP portfolio which includes other awarded and filed patents. Safe Pro Group has expanded international filings to protect the company’s IP rights in several countries and jurisdictions. Safe Pro Group (NASDAQ: SPAI), a developer of AI-powered security and defense solutions, recently announced the filing of the company’s most recent patent application (https://ibn.fm/G982Q). The patent is for Safe Pro’s AI-powered computer vision technology that…

ThursdayDec 18, 2025 10:30 am

Strawberry Fields REIT Inc. (NYSE American: STRW) CEO Highlights Discipline, Scale, and Steady Returns at NobleCon21

Chairman and CEO Moishe Gubin used his NobleCon21 presentation to outline Strawberry Fields REIT’s disciplined expansion strategy and long-term approach to healthcare real estate. The company now holds long-term leasehold interests in 142 healthcare facilities with more than 15,500 licensed beds across 10 states. Gubin emphasized a conservative acquisition philosophy, with each property evaluated from an operator’s perspective despite the company’s role as a self-administered REIT. The REIT has consistently collected 100% of rents and maintains long-term triple-net leases with 3% annual increases. Third-quarter 2025 results showed continued momentum, including rental income of $39.7 million and AFFO of $18.1 million.…

ThursdayDec 18, 2025 9:45 am

Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) Strengthens Indigenous, Community Partnerships to Support Responsible REE Development

A central pillar of Search Mineral’s commitment to the community is its long-standing partnership with the NunatuKavut Community Council The company further reinforces this partnership through its governance structure Search Minerals also maintains frequent dialogue with leaders in St. Lewis, Mary’s Harbour and Port Hope Simpson Disseminated on behalf of Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) and may include paid advertising. Search Minerals (TSX.V: SMY) (OTC: SHCMF) is advancing rare earth development in Labrador with a strong focus on community partnership, Indigenous engagement and responsible long-term stewardship. As the company advances work across its Critical Rare Earth Element (“CREE”)…

ThursdayDec 18, 2025 9:00 am

Insider Confidence and Record Results Highlight OptimumBank Holdings Inc. (NYSE American: OPHC) Momentum in South Florida

Director Michael Blisko’s open-market share purchase signals ongoing insider confidence in OptimumBank’s outlook. The Bank posted its strongest quarter on record in Q3 2025, with net earnings of $4.32 million and ROE of about 22.6%. Net interest margin expanded to 4.37%, supported by higher-yielding loans and disciplined funding costs. Assets topped $1.08 billion and deposits approached $960 million, extending multi-year growth trends. Management continues to emphasize relationship banking and selective expansion across South Florida. OptimumBank Holdings (NYSE American: OPHC), a community and business bank serving Florida, entered the final quarter of 2025 with a visible signal of internal confidence and…

WednesdayDec 17, 2025 9:45 am

Forward Industries Inc. (NASDAQ: FWDI) Gains Buy Rating as Solana-Focused Treasury Strategy Strengthens Outlook

Earlier this year, Forward Industries pivoted toward digital asset management, transforming into the world’s largest Solana-based DAT. The Oak Ridge report observes a notable expansion in institutional activity even amid the downturn in the crypto market. The report highlights the company’s rapid expansion of its digital infrastructure. Forward Industries (NASDAQ: FWDI) is the focus of a new analyst report from Oak Ridge Financial, which reiterates a Buy rating and establishes a $10 price target. The report highlights the company’s ongoing transformation into the world’s largest Solana-based Digital Asset Treasury (“DAT”) and evaluates why analysts believe the company may be positioned…

WednesdayDec 17, 2025 9:00 am

Oncotelic Therapeutics Inc. (OTLC) Leverages Nanoparticles to Re-Imagine Drug Delivery in Oncology

Research indicates that the advantages of nanoparticle delivery in pharma are significant Oncotelic Therapeutics has advanced nanoparticle-based delivery strategies through its joint venture entity, involving its Deciparticle platform Oncotelic is leveraging the very concepts of nanoparticle-mediated delivery in a real-world clinical context In the evolving landscape of pharmaceutical innovation, nanoparticles are rapidly transforming how we think about drug delivery, and Oncotelic Therapeutics (OTCQB: OTLC) is placing itself at the heart of that transformation by applying ultra-small carrier technologies to elevate existing cancer therapies. The company is pioneering how nanotechnology can enhance bioavailability, precision targeting and therapeutic performance of anticancer compounds.…

TuesdayDec 16, 2025 10:30 am

Beyond the Tangled Web: How SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Solves the Battlefield Problem Fiber-Optic Drones Created

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. Fiber-optic drones have become essential for evading electronic warfare but leave hazardous cable webs across battlefields that force soldiers to move with extreme caution SPARC AI's GPS-free navigation and targeting technology eliminates the need for physical tethers, delivering precision without leaving battlefield debris The company's recent STRIKE-1 drone acquisition and pixel-level geolocation capability position it as a software-first alternative to hardware-dependent solutions in contested environments On modern battlefields, the solution to one problem has created another. To counter pervasive electronic warfare and signal jamming,…

TuesdayDec 16, 2025 9:45 am

Strategic Metals and Nevada’s Mining Renaissance: Why Fairchild Gold Corp. (TSX.V: FAIR) (OTCID: FCHDF) Is Positioned for America’s Next Resource Cycle

Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCID: FCHDF) and may include paid advertising. Nevada Titan sits in the historic Goodsprings district, where recent sampling returned grades up to 34% copper with gold and silver credits across a 1.5-kilometer corridor Fairchild acquired Carlin Queen in October 2025, positioned at the intersection of the Carlin Trend (98 million ounces produced) and Midas-Hollister corridor Golden Arrow acquisition adds a NI 43-101 historic resource metric (from 2018 and currently being updated) of measured and indicated 12,172,000 million tons averaging 0.024 oz/ton Au and 0.33 oz/ton Ag, yielding 296,500 oz Au and…

TuesdayDec 16, 2025 9:00 am

Beeline Holdings Inc. (NASDAQ: BLNE) Targets Faster, Simpler Mortgages, as It Expands AI-Driven Lending Model

The company is positioning itself as a digital-first mortgage and title platform aimed at reducing friction and accelerating loan approvals. Its AI-powered system can provide borrowers with a qualification decision in seven to eight minutes, offering 90% certainty of qualification. The fintech lender is targeting two large demographics: millennials and Gen Z buyers seeking access to mortgages for personal or investment purposes, as well as baby boomers who hold an estimated $10 trillion in home equity. Beeline announced that its lending entity achieved cash-flow positivity in October, and the firm is targeting company-wide cash-flow positivity in the first quarter of…

MondayDec 15, 2025 9:45 am

Antisense’s Moment: How Rational Design Is Rewriting Drug Development Economics

Industry data shows small molecules achieve 5–10% approval rates over 15–20 years; antisense oligonucleotides (“ASOs”) are shifting the odds through rational design. Six new antisense drugs gained FDA approval in 2023–2024, bringing total approvals above 20; evidence of accelerating regulatory momentum. Oncotelic Therapeutics’ OT-101 (Trabedersen) is the only TGF-β2-specific antisense in Phase 3 trials, targeting pancreatic cancer and other resistant malignancies. The pharmaceutical industry has long faced sobering odds: about 90% of drug candidates fail before reaching market. For small molecules, approval rates hover at very low odds, often requiring up to two decades of development. In oncology, success rates…

Site Search

Company Search

Category: News